Hawkins D A, Fontaine E A, Thomas B J, Boustouller Y L, Taylor-Robinson D
Division of Sexually Transmitted Diseases, Clinical Research Centre, Harrow, Middlesex.
Genitourin Med. 1988 Feb;64(1):10-3. doi: 10.1136/sti.64.1.10.
Although up to about half the cases of acute non-gonococcal urethritis (NGU) are caused by Chlamydia trachomatis organisms (chlamydiae) and a smaller, ill-defined, proportion probably by Ureaplasma urealyticum organisms (ureaplasmas), the aetiology of all cases is not understood. Clarification of the role of the anaerobe, Bacteroides ureolyticus, was sought in the current study. Seventy five chlamydia negative patients with NGU were treated on a double blind placebo controlled basis with metronidazole. After seven days more of the 35 patients given this drug tended to improve clinically than the 40 given the placebo, but the difference was not significant. Of 23 chlamydia negative but anaerobe positive men, however, 78% (7/9) receiving metronidazole responded clinically, but only 7% (1/14) receiving placebo responded (p less than 0.001). Furthermore, whereas 78% of the anaerobe positive men given metronidazole recovered, only 23% (6/26) of the anaerobe negative men did so (p less than 0.02). No further evidence for the role of ureaplasmas in the aetiology of NGU was obtained, but the data suggest that B ureolyticus organisms, and perhaps other anaerobes, have an important role in a small proportion of cases and that the beneficial effects of metronidazole given on an empirical basis will be confined to anaerobe positive urethritis.
虽然高达约一半的急性非淋菌性尿道炎(NGU)病例是由沙眼衣原体(衣原体)引起的,还有一小部分比例不明的病例可能是由解脲脲原体(脲原体)引起的,但所有病例的病因尚不清楚。在当前研究中,试图阐明厌氧性解脲拟杆菌的作用。75例衣原体阴性的NGU患者在双盲安慰剂对照的基础上接受甲硝唑治疗。7天后,服用该药的35例患者中,临床上倾向于改善的人数比服用安慰剂的40例患者多,但差异不显著。然而,在23例衣原体阴性但厌氧阳性的男性中,接受甲硝唑治疗的患者有78%(7/9)临床上有反应,而接受安慰剂治疗的患者只有7%(1/14)有反应(p小于0.001)。此外,服用甲硝唑的厌氧阳性男性中有78%康复,而厌氧阴性男性中只有23%(6/26)康复(p小于0.02)。没有获得关于脲原体在NGU病因中作用的进一步证据,但数据表明,解脲拟杆菌,也许还有其他厌氧菌,在一小部分病例中起重要作用,并且经验性给予甲硝唑的有益效果将仅限于厌氧阳性尿道炎。